A recent Kaiser
Family Foundation survey illustrates a huge problem facing seniors
who stand to be profoundly affected by the outcome of America's
Medicare prescription drug debate: Too many know far too little
about it.
The Kaiser survey
also reveals that seniors don't understand what the bills recently
passed by the House and Senate will mean for Medicare.
Among
congressional offices, however, a preliminary survey by Heritage
Foundation staff shows a profound unwillingness even to comment on
key issues, as well as evident confusion or logically conflicting
views on broader Medicare policy objectives.
What
Seniors Don't Know About the Medicare Bills
Among the key findings of the
survey:
- 68 percent of
seniors surveyed by the Kaiser Family Foundation didn't know
whether there were any differences between the House and Senate
bills, though there are significant differences.
- Only 34 percent
of seniors have a favorable impression of the current Medicare
proposals in Congress.
- Even though such
a high percentage of seniors admit to having too little knowledge
of these bills, 54 percent of them think Congress should enact this
legislation this year.
- 63 percent were
either very or somewhat worried that a Medicare prescription drug
bill would change Medicare too much. Yet 68 percent are
either very or somewhat worried that the bill will not go far
enough in reforming Medicare.
- 64 percent of
seniors were very or somewhat worried that the bill would be too
costly to taxpayers, and 55 percent answered they were concerned
that the bill would expand the role of government too much.
The Role of
Government
It is ironic that a majority of seniors are concerned about an
excessive expansion of the role of government. While still not a
central issue in the House-Senate conference, where Members are
haggling over the details of a massive entitlement expansion, the
role of government is in fact a key issue facing the Medicare
program.
The governance
question, how Medicare actually works and would work in the future,
is a key issue in Medicare reform. As policy analysts of every
political persuasion know, Medicare is heavily micromanaged by both
the Congress and the Centers for Medicare and Medicaid Services,
the agency that runs the program. The problems of bureaucratic
complexity, centralized planning, and excessive red tape are indeed
creating a managerial crisis in Medicare and discouraging both
doctors and other medical professionals. These growing managerial
problems are also a contributing cause of the increasing
difficulties that some newly retired Americans encounter in even
getting an appointment to see a doctor. For example:
- In 2001, 40
percent of seniors reported having to wait more than a week to see
a doctor when they were sick.
- Also in 2001,
only 71.1 percent of doctors were accepting new Medicare patients,
down from 74.6 percent in 1997.
What
Congress Won't Say About the Medicare Bills
While seniors are evidently confused and unsure about the pending
Medicare legislation, most Members of Congress, based on a survey
of their offices, aren't even talking about it.
The staff of the
Center for Health Policy Studies at The Heritage Foundation
conducted an anonymous survey among members of four important
committees involved in federal health policy or the drafting and
amending the Medicare legislation now in a House-Senate conference
committee. The Heritage staff agreed to keep the names of
respondents and their responses to the questions on the legislation
confidential. The universe of Members were those on the following
committees: the Senate Finance Committee; the Senate Health,
Education, Labor and Pensions Committee; the House Ways and Means
Committee; and the House Energy and Commerce Committee. The offices
of 139 Members were contacted three times each between July 25 and
August 11. There were 12 questions on key policy issues facing the
House-Senate Medicare conference. Only 40 of 139 offices responded:
14 of 60 Democrats (23 percent); 26 of 78 Republicans (33 percent);
and 0 of 1 Independent. In other words, only 28 percent of
congressional offices contacted responded to the survey.
While the low
response rate made a valid survey impossible, some revealing
insights can still be gleaned from the limited data that were
collected. Take just two key issues:
- The displacement
of private coverage, and
- The government
standardization of private health insurance options.
Patients
Being Dumped Out of Private Drug Coverage
A central issue in the current
Medicare drug debate is whether the creation of a universal drug
entitlement will lead to "a crowd out" of existing private drug
coverage, particularly the coverage now provided by employers to
retirees. The congressional office responses to this issue were
instructive.
Of the responding
Democrats:
-
86 percent opposed seniors being dumped
from their employer-provided coverage into a new Medicare
entitlement,
-
Yet 36 percent of them said they
favor the federal
government supplanting private-sector coverage for
retirees.
Of the respondents who favored the
government supplanting private-sector financing and delivery of
prescription drugs for seniors:
-
All opposed private companies dropping
covered retirees, and
-
80 percent favored providing new
taxpayer subsidies to companies to prevent them from
dumping,
-
The remaining 20 percent were
unsure.
Of the responding
Republicans:
-
12 percent support the idea of the
government supplanting the private sector in the financing and
delivery of drugs, and
-
All of them also support subsidies to
private companies in hopes of preventing the dumping of
retirees.
-
15 percent of responding Republicans do
not oppose seniors being dumped by their private-sector retiree
drug coverage,
-
Yet 75 percent favor providing subsidies
to companies to maintain the private insurance that they don't
oppose seniors losing.
Essentially, these members favor having
government be the only entity that provides any form of
prescription drug benefit to seniors but also oppose letting companies stop providing
that coverage because the government is willing to pay for it. They
are also willing to provide these companies with tax dollars or
other forms of relief to prevent them from doing something they say
they essentially support.
Government Regulation of Private Benefit
Packages
Responding Members were
asked whether they supported a provision in the Senate bill (S. 1)
that would require the standardization of the benefits offered to
seniors, essentially the same benefit for everyone. They were also
asked whether they believed seniors had a right to choose their own
private plan.
-
While no Republican respondents favored
the government standardizing benefits for seniors as would be the
case under S. 1, 58 percent of Democrat respondents did. Of those
who stated their support for standardized benefits, 87 percent of
these responding Democrats supported seniors' right to choose their
own private plans. (Presumably, in other words, one would have a
right to choose a private health plan as long as the benefits were
the same as the private health plan one did not choose.) On the
Republican side, 12 percent of congressional offices said that
their Members supported the government supplanting all private
coverage for prescription drugs for seniors, but these same
congressional respondents also said they supported seniors' right
to choose their own private health plan.
Seniors
Confused, Congress Mute
As the recent Kaiser Family
Foundation survey reveals, many seniors are indeed confused about
the proposed Medicare legislation now in a House-Senate conference
committee. As the more limited Heritage staff survey of
congressional offices reveals, many Members of Congress are simply
not talking about the most important issues emerging from the
Medicare debate. These issues will affect the lives of millions of
Americans. Moreover, those that do respond seem profoundly
conflicted on some of the major issues in the current Medicare
debate.
The author thanks
interns John Dayton and Ian Ellis for conducting and organizing the
data of The Heritage Foundation survey.
Kaiser Family Foundation
and Harvard School of Public Health, "Medicare Prescription Drug
Survey," August 2003, at .